|
C6ORF150 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.863400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.641800E-01 |
| Normal-vs-Stage2 |
2.496200E-02 |
| Normal-vs-Stage3 |
7.546000E-01 |
| Normal-vs-Stage4 |
6.322600E-01 |
| Stage1-vs-Stage2 |
1.158530E-03 |
| Stage1-vs-Stage3 |
2.319400E-01 |
| Stage1-vs-Stage4 |
9.623800E-01 |
| Stage2-vs-Stage3 |
2.852400E-02 |
| Stage2-vs-Stage4 |
7.261900E-03 |
| Stage3-vs-Stage4 |
3.927600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.209400E-01 |
| Normal-vs-AfricanAmerican |
8.886400E-01 |
| Normal-vs-Asian |
3.759200E-01 |
| Caucasian-vs-AfricanAmerican |
9.978200E-01 |
| Caucasian-vs-Asian |
3.552200E-01 |
| AfricanAmerican-vs-Asian |
5.531200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.974000E-01 |
| Normal-vs-Female |
9.761200E-01 |
| Male-vs-Female |
8.070600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.418200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.106800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.704400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.338800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.739210E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.967590E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.313600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.403800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.799400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.700200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.922600E-01 |
| Classical-VS-Follicular |
1.71199721066273E-11 |
| Classical-VS-Other |
1.855770E-01 |
| Classical-VS-Normal |
2.493600E-01 |
| Tall-VS-Follicular |
6.09590000000271E-05 |
| Tall-VS-Other |
1.762020E-01 |
| Tall-VS-Normal |
5.160600E-01 |
| Follicular-VS-Other |
4.945000E-01 |
| Follicular-VS-Normal |
1.738000E-03 |
| Other-VS-Normal |
4.186800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.667400E-01 |
| Normal-vs-N1 |
6.901400E-01 |
| N0-vs-N1 |
9.953800E-02 |
|
|
